November 1, 1990Neurology
Neuronal injury due to HIV‐1 envelope protein is blocked by anti‐gp120 antibodies but not by anti‐CD4 antibodies
Authors
Discussion
Loading...
Member takes
Implication
Randomized trial demonstrates anti-gp120 antibodies prevent neuronal injury in cultured neurons, implying novel therapeutic strategies.
Key Points
- The aim is to investigate the neurotoxic effects of HIV-1 envelope protein gp120 and to assess the protective role of specific antibodies.
- Evaluated neurotoxicity of gp120 on rat retinal ganglion cell neurons in culture.
- Administered anti-gp120 and anti-CD4 antibodies to assess protective effects against neuronal injury.
- Analyzed the role of gp120 in mediating injury independent of CD4 binding.
- Neuronal injury was completely blocked by anti-gp120 antibodies.
- Anti-CD4 antibodies did not reduce injury despite known blocking effects in other contexts.
- Suggests that gp120 induces neuronal injury via mechanisms independent of CD4 binding.
Cite This Study
Kaiser et al. (1990) studied this question.